| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Scientific Officer
1 company
Belvin Marcia is a SVP, Chief Scientific Officer at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sale+OE | 13,884 | $2.69 | $37,334.08 | -4.9% | -19.1% | - | |
| Mar 18, 2025 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sell | 19,512 | $0.60 | $11,687.69 | -7.3% | +307.5% | +628.8% | |
| Aug 20, 2024 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sale+OE | 4,181 | $1.23 | $5,138.87 | -2.3% | -30.4% | +58.9% | |
| Mar 19, 2024 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sell | 12,795 | $2.09 | $26,683.97 | -7.1% | -37.2% | -69.3% | |
| Dec 20, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sell | 4,077 | $1.38 | $5,628.30 | -2.6% | +62.7% | -17.9% | |
| Sep 22, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Chief Scientific Officer | Sell | 4,119 | $1.30 | $5,355.94 | -2.7% | +10.2% | -7.0% |